Publication Date
| In 2025 | 1 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Behavior Problems | 1 |
| Biochemistry | 1 |
| Child Development | 1 |
| Clinical Diagnosis | 1 |
| Diagnostic Tests | 1 |
| Diseases | 1 |
| Genetic Disorders | 1 |
| Infants | 1 |
| Intellectual Disability | 1 |
| Patients | 1 |
| Physiology | 1 |
| More ▼ | |
Source
| Journal of Applied Research… | 1 |
Author
| Agustina Sabino Romagnoli | 1 |
| Ayla Gerk | 1 |
| Carina F. Argüelles | 1 |
| Carlos Stegmann | 1 |
| Daniel Fernandez-Guzman | 1 |
| Federico Fernandez Zelcer | 1 |
| Jorgelina Stegmann | 1 |
| Laura F. Sosa | 1 |
| Letícia Nunes Campos | 1 |
| Sofia Wagemaker | 1 |
Publication Type
| Information Analyses | 1 |
| Journal Articles | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Bayley Scales of Infant and… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkAgustina Sabino Romagnoli; Letícia Nunes Campos; Daniel Fernandez-Guzman; Sofia Wagemaker; Federico Fernandez Zelcer; Carlos Stegmann; Carina F. Argüelles; Laura F. Sosa; Ayla Gerk; Jorgelina Stegmann – Journal of Applied Research in Intellectual Disabilities, 2025
Background: Mucopolysaccharidosis type III (MPS III) is a rare lysosomal storage disease with systemic complications. This scoping review aimed to synthesise evidence regarding methods to diagnose and monitor MPS III. Methods: We searched 10 databases for English and Spanish citations published from 2017 to 2022. Our study focused on human-based…
Descriptors: Clinical Diagnosis, Patients, Genetic Disorders, Diseases
